Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BE | LIN |
|---|---|---|
| Price | $264.73 | $470.08 |
| Change today | ▼ 3.80% | ▲ 0.08% |
| Market cap | $77.97B | $216.70B |
| Return, 3 months | -18.8% | -8.6% |
| Return, year to date | +204.7% | +11.3% |
| Return, 1 year | +282.7% | +0.5% |
| P/E (TTM) | 343.8 | 30.3 |
| P/B | 48.4 | 5.5 |
| P/E percentile vs own 5y | 85th | 5th |
| Dividend yield | – | 1.32% |
| Revenue growth (YoY, latest qtr) | +165.5% | +9.3% |
| Net profit growth (YoY) | +571.3% | +9.2% |
| Gross margin | 31.2% | 48.3% |
| Operating margin | 11.2% | 27.1% |
| Net margin | 7.9% | 20.4% |
| Return on equity | 22.2% | 18.7% |
| Analyst target vs. price | +5.2% | +19.2% |
| Analyst buy share | 53% | 85% |
| RSI (14) | 61 | 48 |
| 30-day volatility | 77.7% | 15.7% |
| Max drawdown, 1 year | -52.7% | -19.2% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.